158 related articles for article (PubMed ID: 22211725)
1. Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice.
Flohil SC; van Tiel S; Koljenović S; Jaanen-van der Sanden G; Overbeek LI; de Vries E; Nijsten T
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):907-11. PubMed ID: 22211725
[TBL] [Abstract][Full Text] [Related]
2. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
3. [Basal cell carcinoma: often more than one].
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Ned Tijdschr Geneeskd; 2011; 155(47):A4110. PubMed ID: 22129810
[TBL] [Abstract][Full Text] [Related]
4. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
5. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions.
de Vries E; Micallef R; Brewster DH; Gibbs JH; Flohil SC; Saksela O; Sankila R; Forrest AD; Trakatelli M; Coebergh JW; Proby CM;
Arch Dermatol; 2012 Mar; 148(3):347-54. PubMed ID: 22431775
[TBL] [Abstract][Full Text] [Related]
6. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
8. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions.
Flohil SC; Proby CM; Forrest AD; van Tiel S; Saksela O; Pitkänen S; Ahti T; Micallef R; de Vries E;
Br J Dermatol; 2012 Aug; 167 Suppl 2():22-8. PubMed ID: 22881584
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey.
Bernard P; Dupuy A; Sasco A; Brun P; Duru G; Nicoloyannis N; Grob JJ
Dermatology; 2008; 216(3):194-9. PubMed ID: 18182809
[TBL] [Abstract][Full Text] [Related]
11. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
Schreuder K; Hollestein L; Nijsten TEC; Wakkee M; Louwman MWJ
Br J Dermatol; 2022 Mar; 186(3):476-484. PubMed ID: 34726263
[TBL] [Abstract][Full Text] [Related]
12. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
14. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
16. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
17. Validation of a large basal cell carcinoma registry.
Asgari MM; Eide MJ; Warton EM; Fletcher SW
J Registry Manag; 2013; 40(2):65-9. PubMed ID: 24002130
[TBL] [Abstract][Full Text] [Related]
18. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of metachronous basal cell carcinomas: a prognostic model.
Smedinga H; Verkouteren JAC; Steyerberg EW; Hofman A; Nijsten T; Vergouwe Y
Br J Dermatol; 2017 Oct; 177(4):1113-1121. PubMed ID: 28664573
[TBL] [Abstract][Full Text] [Related]
20. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
